Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brossart

Showing results (121-130 of 266) with videos related to

Pageof 27
Sort By:
Cancer Treatment Reviews|June 8, 2026
Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinomaTessa Hattenhauer, Rebekka Mispelbaum, Franz-Georg Bauernfeind, et al.
JAMA Oncology|December 26, 2024
Dissection of Progressive Disease Patterns for a Modified Classification for ImmunotherapyJonas Saal, Markus Eckstein, Manuel Ritter, et al.
Cancer Gene Therapy|March 15, 2003
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancerAlessio Nencioni, Martin R Müller, Frank Grünebach, et al.
The Journal of Biological Chemistry|November 6, 2007
Identification of a lysosomal peptide transport system induced during dendritic cell developmentOzlem Demirel, Zoe Waibler, Ulrich Kalinke, et al.
Translational Oncology|August 28, 2015
Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread-Identification of a Promising Novel therapeutic targetSavita Bisht, Jens Nolting, Ute Schütte, et al.
German Medical Science : GMS E-Journal|August 14, 2009
Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomideAnja Kraemer, Stefan Hauser, Young Kim, et al.
Critical Reviews in Oncology/Hematology|December 7, 2007
The use of dendritic cells in cancer immunotherapyAlessio Nencioni, Frank Grünebach, Susanne M Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathwaysSilke Appel, Anette Rupf, Markus M Weck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cellsYuko Yokoyama, Frank Grünebach, Susanne M Schmidt, et al.
Experimental Hematology & Oncology|August 8, 2015
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myelomaRuth-Miriam Koerber, Stefanie Andrea Erika Held, Annkristin Heine, et al.
Pageof 27

Showing results (121-130 of 266) with videos related to

Sort By:
Pageof 27
Cancer Treatment Reviews|June 8, 2026
Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinomaTessa Hattenhauer, Rebekka Mispelbaum, Franz-Georg Bauernfeind, et al.
JAMA Oncology|December 26, 2024
Dissection of Progressive Disease Patterns for a Modified Classification for ImmunotherapyJonas Saal, Markus Eckstein, Manuel Ritter, et al.
Cancer Gene Therapy|March 15, 2003
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancerAlessio Nencioni, Martin R Müller, Frank Grünebach, et al.
The Journal of Biological Chemistry|November 6, 2007
Identification of a lysosomal peptide transport system induced during dendritic cell developmentOzlem Demirel, Zoe Waibler, Ulrich Kalinke, et al.
Translational Oncology|August 28, 2015
Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread-Identification of a Promising Novel therapeutic targetSavita Bisht, Jens Nolting, Ute Schütte, et al.
German Medical Science : GMS E-Journal|August 14, 2009
Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomideAnja Kraemer, Stefan Hauser, Young Kim, et al.
Critical Reviews in Oncology/Hematology|December 7, 2007
The use of dendritic cells in cancer immunotherapyAlessio Nencioni, Frank Grünebach, Susanne M Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathwaysSilke Appel, Anette Rupf, Markus M Weck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cellsYuko Yokoyama, Frank Grünebach, Susanne M Schmidt, et al.
Experimental Hematology & Oncology|August 8, 2015
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myelomaRuth-Miriam Koerber, Stefanie Andrea Erika Held, Annkristin Heine, et al.
Pageof 27